Tegoprazan
Sponsors
HK inno.N Corporation, Incheon St.Mary's Hospital, Shandong Luoxin Pharmaceutical Group Stock Co., Ltd., Yanqing Li, Pusan National University Hospital
Conditions
Adverse ReactionErosive Reflux DiseaseGastroesophageal Reflux DiseaseGeneral AnesthesiaHealthyHealthy Male VolunteersHealthy VolunteerHelicobacter Pylori Eradication
Phase 1
A Study to Evaluate Safety, Tolerability, and PD of Tegoprazan on Healthy Male Volunteers
CompletedNCT03378284
Start: 2017-12-10End: 2018-01-16Updated: 2018-03-30
Evaluate the PK of Multiple Oral Doses of Tegoprazan, Metronidazole, Tetracycline and Bismuth in Healthy Volunteers
CompletedNCT04066257
Start: 2019-01-17End: 2019-04-25Updated: 2019-08-28
Pharmacokinetic Interaction Between Tegoprazan and NSAIDs After Multiple Oral Dosing in Healthy Male Volunteers
CompletedNCT04639804
Start: 2020-06-06End: 2020-07-29Updated: 2020-11-23
Drug Interaction Study Between Tegoprazan, Bismuth, Amoxicillin and Clarithromycin
CompletedNCT05915871
Start: 2023-03-23End: 2023-04-28Updated: 2023-06-23
A Study to Evaluate the Pharmacokinetics and Food-effect of IN-M00002 Tablet in Healthy Adult Volunteers
Not yet recruitingNCT07277712
Start: 2025-12-27End: 2026-09-30Target: 74Updated: 2025-12-11
Phase 2
Phase 3
Triple Therapy With Tegoprazan in H. Pylori Positive Patients_PILOT
CompletedNCT04128917
Start: 2020-01-21End: 2021-01-29Updated: 2021-05-12
Efficacy and Safety of Tegoprazan Versus Esomeprazole-containing Bismuth Quadruple Therapy for Eradication of Helicobacter Pylori
CompletedNCT05577468
Start: 2022-10-30End: 2023-09-30Updated: 2024-01-10
The Efficacy of Potassium-competitive Acid Blocker in Patients With Laryngopharyngeal Reflux Disease
CompletedNCT05871398
Start: 2019-10-01End: 2023-02-28Updated: 2023-06-01
Phase 4
Study to Evaluate the Efficacy and Safety of Tegoprazan in ERD Patients With Nighttime Heartburn and Sleep Disturbance
CompletedNCT04309916
Start: 2020-05-22End: 2021-11-30Updated: 2022-02-25
A Study to Evaluate the Efficacy and Safety of Tegoprazan in GERD Patients With Nighttime Heartburn
NCT05701540
Start: 2023-03-24End: 2024-12-31Target: 338Updated: 2023-08-03
Efficacy and Safety of a Triple Eradication Scheme for Helicobacter Pylori Based on Tegoprazan vs Esomeprazole
Not yet recruitingNCT06318104
Start: 2024-04-19End: 2025-02-28Target: 160Updated: 2024-03-19
Efficacy and Safety of Tegoprazan and Minocycline Dual Therapy for Helicobacter Pylori Initial Treatment
Active, not recruitingNCT06523764
Start: 2024-11-11End: 2025-10-01Target: 208Updated: 2025-07-03
Effect of Tegoprazan for Elective Surgery Patients Under General Anesthesia
Enrolling by invitationNCT06743243
Start: 2025-07-23End: 2026-12-30Target: 174Updated: 2025-09-05
Clinical Trial for the Comparative Evaluation of Acid Suppression and Symptom Management of Gastroesophageal Reflux Disease With the Administration of Tegoprazan or Pantoprazole
RecruitingNCT06991348
Start: 2024-07-30End: 2025-11-30Target: 128Updated: 2025-07-23
Unknown Phase
Efficacy of Tegoprazan Based Bismuth Quadruple Therapy for Helicobacter Pylori Infection
NCT04674774
Start: 2021-03-04End: 2022-03-31Updated: 2022-02-10
Comparison of Two Dual Therapies in the First-line Treatment of Helicobacter Pylori Infection (SHARE2301)
NCT05870683
Start: 2023-05-24End: 2023-12-30Target: 368Updated: 2023-07-11
Tegoprazan And Lansoprazole Effectiveness in Bleeding Peptic Ulcer Treatment
RecruitingNCT06894992
Start: 2025-05-01End: 2025-12-31Target: 162Updated: 2025-05-29
Tegoprazan-Based Therapies for H. Pylori Eradication: A Randomized Controlled Trial
CompletedNCT06977841
Start: 2025-06-10End: 2026-03-10Updated: 2026-03-25